The risk of emerging new psychoactive substances: The first fatal 3-MeO-PCP intoxication in The Netherlands

J Forensic Leg Med. 2019 Jul:65:101-104. doi: 10.1016/j.jflm.2019.05.011. Epub 2019 May 21.

Abstract

Structural analogs of classic drugs, also called designer drugs, are a booming market due to the easy accessibility on the internet and their legal status. One of those 'legal highs' is an analog of phencyclidine, namely 3-methoxyphencyclidine (3-MeO-PCP). Very few fatalities have been reported where 3-MeO-PCP contributed to the death of an individual. We present the first fatal case in the Netherlands and one of the few worldwide. Postmortem biological samples and the presumed abused unknown substance, sold as ant poison, were obtained. 3-MeO-PCP was detected, and the resulting concentration was 152 μg/l in whole blood. The presumed taken unknown sample was identified as 3-MeO-PCP and thus linked to the victim. The cause of death was a combination of 3-MeO-PCP, amphetamine, and alcohol. Improved diagnostic skills are necessary to face these emerging novel psychoactive substances also in light of public health and social risks.

Keywords: 3-MeO-PCP; Intoxication; LC-HR-MS; Legal highs; Postmortem.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Amphetamine / blood
  • Blood Alcohol Content
  • Chromatography, Liquid
  • Designer Drugs / analysis
  • Designer Drugs / poisoning*
  • Humans
  • Male
  • Mass Spectrometry / methods
  • Netherlands
  • Phencyclidine / analogs & derivatives*
  • Phencyclidine / blood
  • Phencyclidine / poisoning
  • Psychotropic Drugs / blood
  • Psychotropic Drugs / poisoning*
  • Substance-Related Disorders / blood

Substances

  • Blood Alcohol Content
  • Designer Drugs
  • Psychotropic Drugs
  • methoxydine
  • Amphetamine
  • Phencyclidine